Menu

Dr. Kate Hillier's practice focuses on the representation of public and private life sciences companies discovering, developing and marketing biopharmaceutical, vaccine, medical device, diagnostic and digital health products.

Download full bio 

Experience

  • Cell Design Labs Sells to Gilead 

  • Cell Design Labs: Collaboration Agreement with Kite Pharma and Simultaneous Series of Private Financings 

  • 23andMe in its Multi-year Collaboration with GSK 

  • Vir Biotechnology - $143 Million IPO 

  • Principia Biopharma Agrees to Sell to Sanofi for Approximately $3.68 Billion 

  • View all

Education

  • University of Cambridge (Jesus College)
    JD, with First Class honors, 2005

  • Oxford Institute of Legal Practice
    Diploma in Legal Practice, with distinction, 2005

  • Australian and New Zealand College of Anaesthetists
    Fellowship, 2002

  • University of Adelaide
    MBBS (Medicine and Surgery), with distinction
    1996


Admissions & Credentials

California

Washington

England & Wales

Memberships

  • State Bar of California

  • Solicitors Regulation Authority in the United Kingdom

Rankings & Accolades

    Legal 500: Next Generation Partner, Healthcare: Life Sciences